The political desire of the new UK government to foster closer trading relations with the EU post-Brexit can be served via a ...
The European Medicines Agency (EMA) could table proposals next year to relax requirements around the need for comparative ...
UK employers could face a new type of ‘class action’ over pensions under proposals published by the UK Treasury, but other changes to how the Financial Conduct Authority (FCA) and Financial Ombudsman ...
A carbonating drinks device produced by Swedish company Aarke infringes a SodaStream patent, the UPC Local Division in Düsseldorf has found, granting a permanent injunction in favour of SodaStream in ...
Businesses that make taxable and exempt supplies are referred to as partly exempt, which means that they’re unable to recover all the input tax they have been charged. When making a calculation for ...
All parties involved in design-build-operate (DBO) contracts must do their utmost to mitigate the risks of engaging in projects of national significance amid the Kingdom of Saudi Arabia’s (KSA) drive ...
New regulations aimed at encouraging businesses to invest in new networks that could enhance wireless connectivity, and in innovative new telecoms services that could be delivered via those networks, ...
Jon Fisher tells HRNews about the FCA’s survey on culture and non-financial misconduct and the FCA’s new Conduct Rules expected soon. We're sorry, this video is ...
Recently published guidance for the use of artificial intelligence (AI) in court proceedings is now in effect in Singapore. The guide (7-page / 90.3KB PDF) targets generative AI - software that ...
New data laws under consideration in the UK should require greater transparency over the use of AI systems for processing personal data and make clear that scraping copyrighted content from the ...
Employers in the UK who use artificial intelligence (AI) tools for recruitment need to pay attention to their data protection obligations and have oversight of the AI provider’s data protection ...
Advanced therapy medicinal products (ATMPs), such as new cell and gene therapies (CGTs), offer potentially life-changing health benefits to patients with different types of cancers and rare diseases, ...